Growth Metrics

Quest Diagnostics (DGX) Income from Continuing Operations: 2009-2025

Historic Income from Continuing Operations for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $251.0 million.

  • Quest Diagnostics' Income from Continuing Operations rose 8.66% to $251.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $986.0 million, marking a year-over-year increase of 13.59%. This contributed to the annual value of $902.0 million for FY2024, which is 2.27% up from last year.
  • Quest Diagnostics' Income from Continuing Operations amounted to $251.0 million in Q3 2025, which was down 12.54% from $287.0 million recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Income from Continuing Operations ranged from a high of $640.0 million in Q2 2021 and a low of $113.0 million during Q4 2022.
  • Moreover, its 3-year median value for Income from Continuing Operations was $231.0 million (2024), whereas its average is $230.8 million.
  • In the last 5 years, Quest Diagnostics' Income from Continuing Operations spiked by 414.13% in 2021 and then crashed by 70.88% in 2022.
  • Quest Diagnostics' Income from Continuing Operations (Quarterly) stood at $388.0 million in 2021, then slumped by 70.88% to $113.0 million in 2022, then surged by 74.34% to $197.0 million in 2023, then increased by 17.26% to $231.0 million in 2024, then grew by 8.66% to $251.0 million in 2025.
  • Its last three reported values are $251.0 million in Q3 2025, $287.0 million for Q2 2025, and $217.0 million during Q1 2025.